SABCS 2022: Ibex AI detects different HER2 and HER2 low patterns and helps scoring faint and moderate incomplete cells
At the San Antonio Breast Cancer Symposium, this poster presents a multi-site clinical study conducted by Ibex Medical Analytics, AstraZeneca,







